Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA:600380)
China · Delayed Price · Currency is CNY 12.43
-0.27 (-2.13%)
Nov 17, 2025, 3:00 PM CST
SHA:600380 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 1,366 | 1,387 | 1,443 | 1,503 | 1,328 | 1,120 | Upgrade |
Depreciation & Amortization | 804.62 | 804.62 | 1,054 | 837.7 | 620.45 | 546.91 | Upgrade |
Other Amortization | 280.6 | 280.6 | 76.52 | 65.57 | 43.99 | 39.28 | Upgrade |
Loss (Gain) From Sale of Assets | -37.01 | -37.01 | 2.75 | 17.23 | -17.62 | 1.06 | Upgrade |
Asset Writedown & Restructuring Costs | 21.24 | 21.24 | 0.57 | 14.46 | 1.19 | 10.19 | Upgrade |
Loss (Gain) From Sale of Investments | -55.84 | -55.84 | -53.39 | 19.68 | -48.52 | -192.52 | Upgrade |
Provision & Write-off of Bad Debts | 4.38 | 4.38 | 17.09 | 2.98 | 9.19 | 5.25 | Upgrade |
Other Operating Activities | 2,169 | 1,761 | 1,812 | 1,543 | 1,446 | 1,614 | Upgrade |
Change in Accounts Receivable | 122.42 | 122.42 | 6,974 | 2,381 | -1,594 | -647.41 | Upgrade |
Change in Inventory | -51.29 | -51.29 | -415.39 | -604.73 | -306.33 | -384.21 | Upgrade |
Change in Accounts Payable | -493.78 | -493.78 | -7,047 | -1,925 | 1,037 | 963.8 | Upgrade |
Change in Other Net Operating Assets | -18.05 | -18.05 | 90.25 | 51.13 | 89.63 | 32.53 | Upgrade |
Operating Cash Flow | 4,024 | 3,636 | 3,929 | 3,978 | 2,563 | 3,025 | Upgrade |
Operating Cash Flow Growth | -1.43% | -7.45% | -1.23% | 55.19% | -15.27% | 30.81% | Upgrade |
Capital Expenditures | -886.22 | -979.13 | -1,130 | -1,148 | -1,521 | -830.41 | Upgrade |
Sale of Property, Plant & Equipment | 31.71 | 1.5 | 15.3 | 3.1 | 9.4 | 49.08 | Upgrade |
Cash Acquisitions | - | - | -22.46 | - | - | - | Upgrade |
Divestitures | -36.86 | -28.47 | - | - | 3.31 | 5.34 | Upgrade |
Investment in Securities | -459.01 | -169.38 | 130.21 | -1,230 | -580.79 | 195.08 | Upgrade |
Other Investing Activities | 26.92 | 21.47 | 129.67 | 122.15 | 125.34 | 80.58 | Upgrade |
Investing Cash Flow | -1,323 | -1,154 | -877.42 | -2,252 | -1,964 | -500.32 | Upgrade |
Long-Term Debt Issued | - | 6,637 | 4,274 | 5,340 | 3,535 | 2,944 | Upgrade |
Long-Term Debt Repaid | - | -7,309 | -3,831 | -3,752 | -2,621 | -3,130 | Upgrade |
Net Debt Issued (Repaid) | -215.57 | -672.08 | 442.75 | 1,588 | 913.44 | -186.23 | Upgrade |
Issuance of Common Stock | - | 96.56 | 38.12 | 701.08 | 82.58 | 124.68 | Upgrade |
Repurchase of Common Stock | -1,188 | -1,188 | -821.54 | -780.55 | -938.08 | -503.7 | Upgrade |
Common Dividends Paid | -451.16 | -468.15 | -480.86 | -389.04 | -382.47 | -360.94 | Upgrade |
Other Financing Activities | -919.35 | -804.11 | -1,106 | -553.15 | -650.36 | -312.03 | Upgrade |
Financing Cash Flow | -2,774 | -3,036 | -1,927 | 566.12 | -974.9 | -1,238 | Upgrade |
Foreign Exchange Rate Adjustments | -4.67 | 55.48 | 38.41 | 189.29 | -49.29 | -103.99 | Upgrade |
Net Cash Flow | -78.33 | -498.22 | 1,162 | 2,481 | -425.26 | 1,182 | Upgrade |
Free Cash Flow | 3,138 | 2,657 | 2,799 | 2,830 | 1,042 | 2,195 | Upgrade |
Free Cash Flow Growth | 5.70% | -5.06% | -1.10% | 171.67% | -52.53% | 36.37% | Upgrade |
Free Cash Flow Margin | 20.65% | 17.01% | 16.81% | 16.51% | 6.55% | 16.23% | Upgrade |
Free Cash Flow Per Share | 1.72 | 1.42 | 1.47 | 1.49 | 0.54 | 1.12 | Upgrade |
Cash Income Tax Paid | - | -116.68 | -54.22 | 103.82 | -0.08 | 1,286 | Upgrade |
Levered Free Cash Flow | 2,016 | 1,484 | 1,578 | 1,593 | 424.23 | 1,576 | Upgrade |
Unlevered Free Cash Flow | 2,076 | 1,561 | 1,670 | 1,680 | 480.65 | 1,599 | Upgrade |
Change in Working Capital | -529.32 | -529.32 | -423.56 | -25.24 | -820.13 | -119.24 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.